WCLC 2025 - Posters & ePosters-EP.17.28 Duration of Systemic Therapy in Patients With Metastatic EGFR-Mutated NSCLC and Brain Metastases: First vs Third Generation TKIs

EP.17.28 Duration of Systemic Therapy in Patients With Metastatic EGFR-Mutated NSCLC and Brain Metastases: First vs Third Generation TKIs

Asset Subtitle

Alexander Louie

Meta Tag

Speaker Alexander Louie

Topic Global Health, Health Services, and Health Economics